https://www.selleckchem.com/pr....oducts/way-100635.ht
In vivo experiments further confirmed the pro-tumor effect of IL-33 on NSCLC. The study on the underlying mechanism elucidated that IL-33 regulates the expression of miR-128-3p, which can directly target and inhibit the expression of CDIP1. Furthermore, IL-33 regulates the expression of downstream apoptotic proteins such as bax, cyt-c, and caspase3. Rescue experiments demonstrated that miR-28-3p can reverse the effect of IL-33. These findings indicated that IL-33 and miR-128-3p may play a potential role in the diagnosis and treatment
Like
Comment
Share
